As of 2025-05-14, the Relative Valuation of Assembly Biosciences Inc (ASMB) is (74.15) USD. This relative valuation is based on P/E multiples. With the latest stock price at 12.35 USD, the upside of Assembly Biosciences Inc based on Relative Valuation is -700.4%.
The range of the Relative Valuation is (48.17) - (95.92) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 8.8x - 18.2x | 13.8x |
| Forward P/E multiples | 9.2x - 20.4x | 14.4x |
| Fair Price | (48.17) - (95.92) | (74.15) |
| Upside | -490.0% - -876.7% | -700.4% |
| Date | P/E |
| 2025-05-12 | -2.34 |
| 2025-05-09 | -2.33 |
| 2025-05-08 | -2.22 |
| 2025-05-07 | -2.36 |
| 2025-05-06 | -2.40 |
| 2025-05-05 | -2.69 |
| 2025-05-02 | -2.70 |
| 2025-05-01 | -2.18 |
| 2025-04-30 | -2.17 |
| 2025-04-29 | -2.19 |
| 2025-04-28 | -2.06 |
| 2025-04-25 | -2.03 |
| 2025-04-24 | -2.00 |
| 2025-04-23 | -1.98 |
| 2025-04-22 | -1.91 |
| 2025-04-21 | -1.89 |
| 2025-04-17 | -1.91 |
| 2025-04-16 | -1.90 |
| 2025-04-15 | -1.87 |
| 2025-04-14 | -1.94 |
| 2025-04-11 | -1.73 |
| 2025-04-10 | -1.61 |
| 2025-04-09 | -1.64 |
| 2025-04-08 | -1.57 |
| 2025-04-07 | -1.64 |
| 2025-04-04 | -1.66 |
| 2025-04-03 | -1.77 |
| 2025-04-02 | -1.80 |
| 2025-04-01 | -1.79 |
| 2025-03-31 | -1.82 |
| 2025-03-28 | -2.02 |
| 2025-03-27 | -2.07 |
| 2025-03-26 | -2.06 |
| 2025-03-25 | -2.17 |
| 2025-03-24 | -2.11 |
| 2025-03-21 | -2.09 |
| 2025-03-20 | -2.03 |
| 2025-03-19 | -2.06 |
| 2025-03-18 | -2.14 |
| 2025-03-17 | -2.01 |
| 2025-03-14 | -2.07 |
| 2025-03-13 | -2.02 |
| 2025-03-12 | -2.10 |
| 2025-03-11 | -2.06 |
| 2025-03-10 | -2.12 |
| 2025-03-07 | -2.11 |
| 2025-03-06 | -2.17 |
| 2025-03-05 | -2.28 |
| 2025-03-04 | -2.27 |
| 2025-03-03 | -2.33 |